Drugmaker Natco Pharma has reported a 14.49% decline in the consolidated net profit to ₹122.1 crore for the quarter ended June 30 even as revenue increased.

In the year-earlier period, it had registered a net profit of ₹142.8 crore. Total revenue for the quarter was ₹582.1 crore (₹513.3 crore) which, the company said, was driven primarily by exports formulations business.

During the quarter, the company faced margin pressure on both domestic and international formulations. Inspite of the lower margins, it is confident of the business for remaining part of the financial year based on the order book and earnings outlook.

The company expects a growth of over 25% in the earnings for 2020-21, a release said.

In terms of revenue split, the company said active pharmaceutical ingredients (API) segment contributed to ₹143.92 crore, while the share of formulations (domestic market) was ₹125.62 crore and formulations (export, including profit share and foreign subsidiaries) was ₹274.23 crore. Other operating income was ₹18.35 crore and other income ₹19.95 crore.

Interim dividend

The company has declared an interim dividend of ₹1.25 per share of Rs.2 each for 2020-21. The date for taking a record of its shareholders eligible for the purpose of payment of interim dividend is fixed for August 24.

You have reached your limit for free articles this month.

To get full access, please subscribe.

Already have an account ? Sign in

Show Less Plan

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Faster pages

Move smoothly between articles as our pages load instantly.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.


A one-stop-shop for seeing the latest updates, and managing your preferences.

Personalised recommendations

A select list of articles that match your interests and tastes.


We brief you on the latest and most important developments, three times a day.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.

Source link


Please enter your comment!
Please enter your name here